BR112021006406A2 - forma de dosagem de gonadotrofina coriônica humana (hcg) de liberação prolongada - Google Patents
forma de dosagem de gonadotrofina coriônica humana (hcg) de liberação prolongadaInfo
- Publication number
- BR112021006406A2 BR112021006406A2 BR112021006406A BR112021006406A BR112021006406A2 BR 112021006406 A2 BR112021006406 A2 BR 112021006406A2 BR 112021006406 A BR112021006406 A BR 112021006406A BR 112021006406 A BR112021006406 A BR 112021006406A BR 112021006406 A2 BR112021006406 A2 BR 112021006406A2
- Authority
- BR
- Brazil
- Prior art keywords
- hcg
- chorionic gonadotropin
- human chorionic
- extended release
- dosage form
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Reproductive Health (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
forma de dosagem de gonadotrofina coriônica humana (hcg) de liberação prolongada. a presente divulgação se refere a formas de dosagem de de gonadotrofina coriônica humana (hcg) de liberação prolongada ou seus derivados ou isoformas. as formas de dosagem de hcg de liberação prolongada compreendem microesferas de polímero biodegradável e proporcionam a liberação prolongada de hcg ao longo de um período de tempo desejado.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862740145P | 2018-10-02 | 2018-10-02 | |
PCT/NL2019/050660 WO2020071912A1 (en) | 2018-10-02 | 2019-10-02 | Extended release formulations of human chorionic gonadotropin (hcg) |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112021006406A2 true BR112021006406A2 (pt) | 2021-07-06 |
Family
ID=69063845
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112021006406A BR112021006406A2 (pt) | 2018-10-02 | 2019-10-02 | forma de dosagem de gonadotrofina coriônica humana (hcg) de liberação prolongada |
Country Status (8)
Country | Link |
---|---|
US (1) | US20220062177A1 (pt) |
EP (1) | EP3860573A1 (pt) |
JP (1) | JP2022504427A (pt) |
CN (1) | CN113226289A (pt) |
AU (1) | AU2019354528A1 (pt) |
BR (1) | BR112021006406A2 (pt) |
CA (1) | CA3115186A1 (pt) |
WO (1) | WO2020071912A1 (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019079167A1 (en) | 2017-10-16 | 2019-04-25 | Institute For Cancer Research D/B/A The Research Institute Of Fox Chase Cancer Center | PEPTIDES VARIANTS OF HUMAN CHORIONIC GONADOTROPIN AND TREATMENT OF BREAST CANCER |
WO2022125417A1 (en) * | 2020-12-07 | 2022-06-16 | Institute For Cancer Research D/B/A The Research Institute Of Fox Chase Cancer Center | Treatment of females having brca1/2 mutations with human chorionic gonadotropin to reduce the risk of developing breast cancer |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5665428A (en) * | 1995-10-25 | 1997-09-09 | Macromed, Inc. | Preparation of peptide containing biodegradable microspheres by melt process |
WO2005039502A2 (en) * | 2003-10-24 | 2005-05-06 | Azopax Therapeutics Llc | Macromer-melt formulations |
WO2010017215A2 (en) * | 2008-08-04 | 2010-02-11 | The Regents Of The University Of California | Biodegradable microspheres and methods of use thereof |
ES2600926T3 (es) * | 2011-02-16 | 2017-02-13 | Sanzyme Private Limited | Formulación de liberación controlada que comprende hCG |
EP2734573B1 (en) * | 2011-07-22 | 2021-09-08 | InnoCore Technologies Holding B.V. | Biodegradable, semi-crystalline, phase separated, thermoplastic multi block copolymers for controlled release of biologically active compounds |
MX2016004444A (es) * | 2013-10-08 | 2016-11-10 | Ferring Bv | Microparticulas que comprenden gnrh hechas mediante pgss. |
GB201603280D0 (en) * | 2016-02-24 | 2016-04-13 | Ferring Bv | Stable liquid gonadotropin formulation |
KR20190110567A (ko) * | 2017-01-31 | 2019-09-30 | 베루 인코퍼레이티드 | 성선 자극 호르몬-방출 호르몬(GnRH) 길항제의 장기간 방출을 위한 조성물 및 방법 |
-
2019
- 2019-10-02 WO PCT/NL2019/050660 patent/WO2020071912A1/en unknown
- 2019-10-02 CA CA3115186A patent/CA3115186A1/en active Pending
- 2019-10-02 BR BR112021006406A patent/BR112021006406A2/pt unknown
- 2019-10-02 JP JP2021518949A patent/JP2022504427A/ja active Pending
- 2019-10-02 CN CN201980079274.5A patent/CN113226289A/zh active Pending
- 2019-10-02 AU AU2019354528A patent/AU2019354528A1/en active Pending
- 2019-10-02 EP EP19829697.2A patent/EP3860573A1/en active Pending
- 2019-10-02 US US17/281,902 patent/US20220062177A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2019354528A1 (en) | 2021-05-13 |
CA3115186A1 (en) | 2020-04-09 |
EP3860573A1 (en) | 2021-08-11 |
JP2022504427A (ja) | 2022-01-13 |
WO2020071912A1 (en) | 2020-04-09 |
US20220062177A1 (en) | 2022-03-03 |
CN113226289A (zh) | 2021-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DOP2018000175A (es) | Inhibidores de la proteína quinasa 1 que interactua con el receptor | |
CL2019000477A1 (es) | Un esteroide 19 nor-c21-n-pirazolilo c3,3- disustituido cristalino. | |
DOP2018000297A (es) | Derivado de glucagon, conjugado del mismo, composición que comprende el mismo y uso terapéutico del mismo | |
AR120567A2 (es) | Recubrimiento de fertilizante, gránulo de fertilizante y fertilizante recubierto | |
BR112021006406A2 (pt) | forma de dosagem de gonadotrofina coriônica humana (hcg) de liberação prolongada | |
CL2011000380A1 (es) | Granulo para ser utilizado en la braquiterapia, que comprende una estructura insoluble o coloidal con radioisotopo, una matriz de polimero reabsorbible, que a su vez comprende particulas individuales, consistentes en sorbitol cubierto con un polimero biodegradable; y metodo para la fabricacion de dichos granulos. | |
CL2018001686A1 (es) | Métodos y composiciones particularmente para el tratamiento del trastorno por déficit de atención (divisional solicitud 201701026) | |
DOP2016000109A (es) | Formas sólidas de ácido {[5-(3-clorofenil) -3-hidroxipiridin-2-carbonil] amino} acético, composiciones, y usos de las mismas. | |
PA8770101A1 (es) | Amidas de 4-aril-1,4-dihidro-1, 6-naftiridina sustituidas y su uso | |
CL2022001722A1 (es) | Derivados carboxi con propiedades antiinflamatorias | |
CR20160477A (es) | Nanopartículas terapéuticas que comprenden un agente terapéutico, y métodos para su elaboración y uso | |
AR099572A1 (es) | Artículos para fumar con liberación de un componente líquido que tiene un recubrimiento frágil | |
CY1122725T1 (el) | Αποσμητικη συνθεση που περιλαμβανει ενα μειγμα αλφα, βητα και γαμμα κυκλοδεξτρινων | |
UY37444A (es) | Derivados sustituidos de 6-(1h-pirazol-1-il)pirimidin-4-amina y su uso | |
CO2019011227A2 (es) | N-ariletil-2-aminoquinolin-4-carboxamidas sustituidas y su uso | |
CL2019002020A1 (es) | Una composición farmacéutica que comprende un derivado de oxazina y su uso en el tratamiento o la prevención de la enfermedad de alzheimer. | |
IL283718A (en) | Formulation of a sustained-release drug comprising an outer layer with an enzymatically degradable polymer, its preparation and method of production | |
BR112021026025A2 (pt) | Polímeros biodegradáveis ultrassensíveis ao ph | |
CL2019000452A1 (es) | Composición líquida de porción individual con un componente lácteo, cereales y frutas. | |
DOP2020000093A (es) | Uso de pirrolidonas heteroaromáticas fusionadas para el tratamiento y prevención de enfermedades en animales | |
CL2020000688S1 (es) | Artículo sanitario absorbente. (divisional solicitud 201702698) | |
AR117833A1 (es) | Composición prebiótica y su uso | |
TWD193827S (zh) | Hillside slope fixing equipment | |
PL124883U1 (pl) | Pieluszka | |
CU20180079A7 (es) | Inhibidores de la proteína quinasa 1 que interactúa con el receptor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] |